Transcription and RNA Processing - AP Biology

SECTION 1

Historical Context & Motivation

The discovery that genetic information flows from DNA to RNA to protein stands as one of the most consequential insights in molecular biology. After Watson and Crick elucidated the double-helical structure of DNA in 1953, the scientific community faced an urgent question: how does the information encoded in a stable, nuclear molecule direct the synthesis of proteins in the cytoplasm? The answer required identifying an intermediary molecule — messenger RNA (mRNA) — and the enzyme responsible for copying DNA into RNA, known as RNA polymerase. These discoveries launched decades of research into the mechanisms of transcription and the elaborate processing steps that convert a primary transcript into a mature, functional RNA.

1956 • Discovery of RNA Polymerase Activity

Several labs, including those of Severo Ochoa and Arthur Kornberg, identified enzymatic activities capable of synthesizing RNA from nucleotide precursors, establishing that RNA synthesis is an enzyme-catalyzed process.

1961 • The Messenger RNA Hypothesis

François Jacob and Jacques Monod proposed that a short-lived RNA intermediate — mRNA — carries genetic information from DNA to ribosomes. Sydney Brenner, Jacob, and Matthew Meselson provided experimental evidence the same year.

1970 • Sigma Factor and Promoter Recognition

Richard Burgess and Andrew Travers isolated the sigma (σ) subunit of bacterial RNA polymerase, demonstrating that specific protein factors direct the enzyme to promoter sequences on DNA.

1977 • Discovery of Introns and RNA Splicing

Phillip Sharp and Richard Roberts independently discovered that eukaryotic genes contain non-coding intervening sequences (introns) that are removed from the primary transcript by RNA splicing, fundamentally revising views of gene structure.

1993 • Spliceosome Structure Emerges

Biochemical and genetic studies revealed that intron removal is catalyzed by the spliceosome, a large ribonucleoprotein complex composed of five snRNPs. Later cryo-EM work provided atomic-level structural details.

The central question that unifies this lesson is: how does a cell accurately copy a specific segment of its genome into RNA, and what additional modifications must eukaryotic cells perform before that RNA can function? Understanding transcription and RNA processing is essential not only for the AP Biology exam but for appreciating how gene expression is regulated at multiple levels — from promoter access to alternative splicing — with profound implications for development, disease, and biotechnology.

SECTION 2

Core Principles of Transcription

Transcription is the process by which the information stored in a DNA template is enzymatically copied into a complementary RNA molecule. Although the fundamental logic of transcription — base pairing between DNA and incoming ribonucleotides — is conserved across all domains of life, eukaryotic transcription involves greater complexity in terms of enzyme diversity, regulatory architecture, and post-transcriptional processing. Before exploring the mechanism in detail, it is important to establish the foundational principles that govern how transcription operates.

Template-Directed Synthesis

RNA polymerase reads the template strand (also called the antisense strand) of DNA in the 3′→5′ direction, synthesizing a complementary RNA molecule in the 5′→3′ direction. The resulting RNA has the same base sequence as the coding strand (sense strand), except with uracil (U) replacing thymine (T).

Promoter-Driven Initiation

Transcription begins at specific DNA sequences called promoters. In bacteria, the sigma factor directs RNA polymerase to consensus sequences (e.g., −10 and −35 elements). In eukaryotes, general transcription factors and RNA Polymerase II recognize the TATA box and other core promoter elements.

No Primer Required

Unlike DNA polymerase, RNA polymerase can initiate synthesis de novo — it does not require an RNA primer. This is a critical distinction from DNA replication and reflects the enzyme's ability to catalyze the first phosphodiester bond without a pre-existing 3′-OH group.

Selective Gene Activation

Not all genes are transcribed at the same time or in every cell type. Differential gene expression is achieved through combinatorial control by transcription factors, enhancers, silencers, and chromatin remodeling — allowing the same genome to produce vastly different cell phenotypes.

Eukaryotic RNA Processing

In eukaryotes, the primary transcript (pre-mRNA) undergoes three major processing events: 5′ capping, 3′ polyadenylation, and RNA splicing. These modifications are required for mRNA stability, nuclear export, and efficient translation.

✦

KEY TAKEAWAY

Think of transcription like a recording studio: the DNA template strand is the master recording that never leaves the vault, RNA polymerase is the recording equipment that produces a working copy, and the mRNA is the distributed copy that gets sent out for use (translation). In eukaryotes, the raw recording (pre-mRNA) goes through an editing suite — capping, polyadenylation, and splicing — before it is released as a polished product.

SECTION 3

Visual Overview of Transcription

The following diagram illustrates the three major stages of transcription — initiation, elongation, and termination — showing the spatial relationship between DNA, RNA polymerase, and the growing RNA transcript. Pay particular attention to strand polarity and the direction of polymerase movement.

The three stages of transcription are shown from left to right. During initiation, RNA polymerase (RNAP) binds the promoter and locally unwinds DNA. During elongation, RNAP moves along the template strand (3′→5′), synthesizing mRNA in the 5′→3′ direction. During termination, a terminator signal causes RNAP and the completed mRNA to dissociate from the DNA. Note the base-pairing rules in the lower panel: uracil replaces thymine in RNA.

Note that in the diagram, the coding strand runs 5′→3′ from left to right (pink), while the template strand runs antiparallel 3′→5′ (blue). RNA polymerase reads the template strand and synthesizes the mRNA in the 5′→3′ direction, which means the mRNA sequence is complementary to the template but essentially identical to the coding strand (with U instead of T). On the AP exam, you may be asked to determine the mRNA sequence given either the template or the coding strand — always keep the base-pairing rules and strand polarity in mind.

SECTION 4

Detailed Mechanism of Transcription

Initiation: Assembling the Transcription Machinery

In eukaryotes, transcription of protein-coding genes is carried out by RNA Polymerase II (Pol II), a multi-subunit enzyme that cannot recognize promoters on its own. Instead, a series of general transcription factors (GTFs) — TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH — assemble in a stepwise manner at the core promoter to form the pre-initiation complex (PIC). The process begins when the TATA-binding protein (TBP), a subunit of TFIID, binds the TATA box approximately 25–30 base pairs upstream of the transcription start site. TFIIH then uses its helicase activity to unwind about 11–15 base pairs of DNA, creating the transcription bubble, and its kinase activity phosphorylates the C-terminal domain (CTD) of Pol II, triggering promoter clearance and the transition to elongation.

Elongation: Synthesizing the RNA Transcript

Once Pol II clears the promoter, it enters the elongation phase. The enzyme moves along the template strand in the 3′→5′ direction, adding complementary ribonucleoside triphosphates (NTPs) — ATP, UTP, GTP, and CTP — to the growing RNA chain in the 5′→3′ direction. Each incoming NTP is joined to the 3′-OH of the preceding nucleotide by a phosphodiester bond, releasing pyrophosphate (PP_i), whose subsequent hydrolysis drives the reaction forward. The rate of elongation in eukaryotes is roughly 1,000–2,000 nucleotides per minute. Pol II maintains a short RNA:DNA hybrid of about 8 base pairs within the active site; behind the polymerase, the DNA double helix re-anneals and the nascent RNA strand peels away as a single-stranded molecule.

Termination: Releasing the Transcript

Termination mechanisms differ between prokaryotes and eukaryotes. In bacteria, two well-characterized pathways exist: rho-independent (intrinsic) termination, in which a GC-rich hairpin loop followed by a poly-U stretch in the nascent RNA destabilizes the RNA:DNA hybrid and causes dissociation, and rho-dependent termination, in which the rho (ρ) protein, an ATP-dependent helicase, catches up to a paused polymerase and unwinds the RNA:DNA hybrid. In eukaryotes, Pol II transcription of mRNA genes terminates via the cleavage-polyadenylation model: the pre-mRNA is cleaved at a specific site downstream of the AAUAAA polyadenylation signal, and the remaining RNA still being synthesized by Pol II is degraded by a 5′→3′ exonuclease, which eventually catches the polymerase and triggers termination.

ℹ

Prokaryotes vs. Eukaryotes

In prokaryotes, transcription and translation are coupled — ribosomes begin translating the mRNA while it is still being transcribed, because there is no nuclear membrane separating the two processes. In eukaryotes, transcription occurs in the nucleus and the mature mRNA must be exported to the cytoplasm before translation can begin, creating opportunities for additional layers of regulation.

SECTION 5

Eukaryotic RNA Processing

In eukaryotic cells, the primary transcript produced by RNA Polymerase II — called pre-mRNA — undergoes three critical processing events before it is exported from the nucleus as mature mRNA. These modifications occur co-transcriptionally (while transcription is still underway) and are essential for mRNA stability, proper nuclear export, and efficient translation. The three events are 5′ capping, 3′ polyadenylation, and RNA splicing.

This diagram traces the transformation of pre-mRNA into mature mRNA through four steps. The 5′ cap (green, 7-methylguanosine) is added first, followed by cleavage and polyadenylation at the 3′ end (red). Splicing removes introns (purple/pink) and joins exons (gold then cyan) to produce the continuous open reading frame of the mature mRNA.

5′ Capping

As soon as the first 20–30 nucleotides of the pre-mRNA emerge from RNA Polymerase II, capping enzymes add a 7-methylguanosine (7mG) residue to the 5′ end through an unusual 5′→5′ triphosphate linkage. This cap serves multiple functions: it protects the mRNA from degradation by 5′ exonucleases, facilitates recognition by the nuclear cap-binding complex (CBC) for export through nuclear pores, and is later recognized by the eukaryotic initiation factor eIF4E during translation initiation. Without the cap, the mRNA would be rapidly degraded and would fail to engage the ribosomal machinery.

3′ Polyadenylation

The 3′ end of the pre-mRNA is processed by endonucleolytic cleavage at a site 10–30 nucleotides downstream of the highly conserved AAUAAA polyadenylation signal. After cleavage, the enzyme poly-A polymerase (PAP) adds approximately 100–250 adenine nucleotides to form the poly-A tail. This tail enhances mRNA stability by slowing 3′ exonuclease degradation, assists in nuclear export, and stimulates translation efficiency. The length of the poly-A tail can influence mRNA lifespan — a shorter tail is associated with more rapid degradation.

RNA Splicing

Most eukaryotic protein-coding genes contain introns (non-coding intervening sequences) interspersed among exons (expressed sequences). In some human genes, introns may comprise more than 90% of the primary transcript. The removal of introns and the joining of exons is catalyzed by the spliceosome, a large ribonucleoprotein (RNP) complex composed of five small nuclear ribonucleoproteins (snRNPs: U1, U2, U4, U5, U6) and many associated proteins. Splicing proceeds through two sequential transesterification reactions. First, the 2′-OH of a conserved branch-point adenine within the intron attacks the 5′ splice site, forming a lariat intermediate. Second, the free 3′-OH of the upstream exon attacks the 3′ splice site, joining the two exons and releasing the intron lariat for degradation.

💡

Alternative Splicing — Expanding Protein Diversity

A single gene can produce multiple mRNA variants through alternative splicing, in which different combinations of exons are included or excluded. This mechanism explains how the ~20,000 human protein-coding genes can give rise to an estimated 100,000+ distinct proteins. For example, the Drosophila DSCAM gene can theoretically produce over 38,000 mRNA isoforms through combinatorial exon selection. Alternative splicing is a critical concept for AP Biology because it illustrates how post-transcriptional regulation expands the informational capacity of the genome.

SECTION 6

Worked Example: From DNA to Mature mRNA

Consider the following problem, which integrates transcription and RNA processing. You are given a segment of a eukaryotic gene and asked to determine the sequence of the mature mRNA.

Determining Mature mRNA Sequence

1
Step 1 — Identify the Given Information

A portion of a eukaryotic gene has the following coding (sense) strand sequence (written 5′→3′): 5′-ATG·GCA·|·GTA·AGG·TCA·|·TTT·GCC·TAA-3′. The vertical bars (|) denote exon-intron boundaries. Exon 1 = ATG GCA, Intron = GTA AGG TCA, Exon 2 = TTT GCC TAA. The template strand is the complement read 3′→5′.
2
Step 2 — Write the Pre-mRNA Sequence

The pre-mRNA has the same sequence as the coding strand but with U replacing T: 5′-AUG·GCA·GUA·AGG·UCA·UUU·GCC·UAA-3′. This is the primary transcript before any processing.

Pre-mRNA: 5′-AUG GCA GUA AGG UCA UUU GCC UAA-3′
3
Step 3 — Apply 5′ Capping and 3′ Polyadenylation

A 7-methylguanosine cap is added to the 5′ end (shown as 7mG–), and a poly-A tail (~100–250 As) is added to the 3′ end. The coding sequence itself is not altered by these modifications, but they are crucial structural features of the mature mRNA.

7mG–5′-AUG GCA [GUA AGG UCA] UUU GCC UAA-3′-AAAAAA...A
4
Step 4 — Remove the Intron via Splicing

The spliceosome recognizes the intron boundaries and removes the intron sequence GUA AGG UCA, joining Exon 1 directly to Exon 2. The exons are ligated by a phosphodiester bond.

Mature mRNA: 7mG–5′-AUG GCA UUU GCC UAA-3′-AAAAAA...A
5
Step 5 — Verify the Reading Frame

Reading the mature mRNA in triplet codons from the start codon AUG: AUG (Met) – GCA (Ala) – UUU (Phe) – GCC (Ala) – UAA (stop). The mRNA encodes a 4-amino-acid polypeptide: Met-Ala-Phe-Ala. Notice that the intron interrupted the coding sequence but, upon removal, the reading frame was preserved — this is a fundamental requirement of proper splicing.

Polypeptide: Met-Ala-Phe-Ala

SECTION 7

Prokaryotic vs. Eukaryotic Transcription

Although the fundamental chemistry of RNA synthesis is conserved, prokaryotic and eukaryotic transcription differ significantly in terms of enzyme complexity, regulatory mechanisms, and post-transcriptional processing. The following table summarizes the key distinctions that are frequently tested on the AP Biology exam.

Feature	Prokaryotes	Eukaryotes
RNA Polymerase	Single type (core enzyme + σ factor)	Three types: Pol I (rRNA), Pol II (mRNA), Pol III (tRNA, 5S rRNA)
Promoter Elements	−10 (Pribnow box) and −35 consensus sequences	TATA box, Inr, DPE; enhancers may be thousands of bp away
Transcription Factors	σ factor for initiation; few additional regulators	Multiple GTFs (TFIIA–H); Mediator complex; numerous activators/repressors
mRNA Processing	None (mRNA is ready for translation immediately)	5′ cap, poly-A tail, intron splicing
Coupling with Translation	Yes — co-transcriptional translation	No — transcription in nucleus, translation in cytoplasm
Termination	Rho-dependent or rho-independent (intrinsic)	Cleavage-polyadenylation coupled with torpedo model
Gene Structure	Genes typically lack introns; operons group related genes	Most genes contain introns; monocistronic mRNAs

Key differences between prokaryotic and eukaryotic transcription

Coupled and compartmentalized expression.

The bacterial example couples translation to emerging RNA. In the eukaryotic example, nuclear transcription and processing precede RNA export and cytosolic translation. The selected bacterial model couples transcription with translation on emerging RNA. The eukaryotic comparison places transcription and processing inside a nucleus and translation after pore-mediated export to cytosol; the two cell windows use different schematic scales.

✦

KEY TAKEAWAY

Think of prokaryotic gene expression as a streamlined assembly line with minimal quality control — the product (mRNA) goes directly to use. Eukaryotic gene expression is more like a pharmaceutical manufacturing pipeline, with multiple checkpoints (capping, splicing, polyadenylation, export) that ensure only properly processed transcripts reach the translation machinery. This added complexity allows for far more sophisticated regulation but also creates more potential points of failure, which is relevant to understanding how mutations in splicing signals can cause genetic disease.

SECTION 8

Connections to Regulation and Disease

Transcription and RNA processing are not merely mechanical steps in gene expression — they are heavily regulated and serve as critical control points that determine which proteins a cell produces, when, and in what quantities. Understanding these connections is essential for the AP Biology exam and for appreciating the broader significance of gene regulation in development, cellular differentiation, and disease.

Concept in This Lesson	Advanced Connection
Promoter recognition by Pol II	Epigenetic modifications (DNA methylation, histone acetylation) regulate promoter accessibility. CpG island hypermethylation can silence tumor suppressor genes, contributing to cancer.
Enhancers and transcription factors	Combinatorial control by multiple transcription factors enables cell-type-specific gene expression. Mutations in enhancers can cause developmental disorders (e.g., limb malformations from Shh enhancer mutations).
Alternative splicing	Aberrant splicing accounts for ~15% of human genetic diseases. For example, certain mutations in the SMN1 gene cause spinal muscular atrophy by disrupting normal splicing patterns.
Poly-A tail length	mRNA stability regulation through poly-A tail shortening (deadenylation) is a post-transcriptional control mechanism. MicroRNAs (miRNAs) can accelerate deadenylation and mRNA degradation.
5′ cap recognition	mRNA vaccines (e.g., COVID-19) use synthetic mRNAs with modified 5′ caps and optimized UTRs to enhance stability and translation in host cells — a direct biomedical application of RNA processing principles.

How transcription and RNA processing connect to advanced topics

As you advance beyond the foundational material covered in this lesson, keep in mind that transcription is the first — and often the most important — regulatory step in gene expression. The concepts of transcriptional regulation (operons in prokaryotes, enhancers and chromatin remodeling in eukaryotes) and post-transcriptional regulation (alternative splicing, mRNA stability, RNA interference) are deeply tested on the AP Biology exam. Future lessons will explore these regulatory layers in detail, building upon the mechanistic foundations established here.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Which of the following best explains why eukaryotic mRNA must undergo processing before translation, whereas prokaryotic mRNA does not?

A. Eukaryotic RNA polymerase makes more errors than prokaryotic RNA polymerase, requiring correction through processing.
B. Eukaryotic genes contain introns that must be removed, and the mRNA requires modifications for stability and nuclear export, whereas prokaryotic genes generally lack introns and mRNA is translated immediately in the cytoplasm.
C. Prokaryotic ribosomes can translate RNA with introns still present, while eukaryotic ribosomes cannot.
D. Eukaryotic mRNA is chemically different from prokaryotic mRNA and requires capping before ribonucleotides can form phosphodiester bonds.

Show answer (B)

B is correct. Eukaryotic genes contain introns that must be spliced out, and the mature mRNA needs a 5′ cap and poly-A tail for stability and nuclear export before it can reach cytoplasmic ribosomes. Prokaryotic genes typically lack introns, and since there is no nuclear membrane, ribosomes begin translating the mRNA co-transcriptionally. A is incorrect because RNA processing does not serve as an error-correction mechanism; proofreading in transcription is minimal in both domains. C is incorrect because prokaryotic genes generally do not have introns to begin with, not because their ribosomes tolerate intron sequences. D is incorrect because the chemical composition of mRNA (ribonucleotides linked by phosphodiester bonds) is fundamentally the same in prokaryotes and eukaryotes; capping occurs after transcription has already begun.

Question 2: BASIC

A segment of the template (antisense) strand of a gene reads 3′-TACGGATTC-5′. What is the sequence of the mRNA transcribed from this template?

A. 5′-AUGCCUAAG-3′
B. 5′-ATGCCTAAG-3′
C. 5′-GAAUCCGUA-3′
D. 5′-UACGGAUUC-3′

Show answer (A)

A is correct. RNA polymerase reads the template strand 3′→5′ and synthesizes the mRNA 5′→3′. Applying complementary base pairing (A→U, T→A, G→C, C→G): Template 3′-T A C G G A T T C-5′ yields mRNA 5′-A U G C C U A A G-3′. B is incorrect because it uses thymine (T) instead of uracil (U). The sequence 5′-ATGCCTAAG-3′ represents the coding (sense) DNA strand, not the mRNA transcript. RNA contains uracil in place of thymine. C is incorrect because it represents the complement of the coding strand read in the wrong direction. The sequence 5′-GAAUCCGUA-3′ would result from incorrectly reading the template strand 5′→3′ instead of the correct 3′→5′ direction, producing a reversed complement. D is incorrect because it is a direct copy of the template strand with T→U substitution (5′-UACGGAUUC-3′) rather than the complement. The mRNA must be complementary and antiparallel to the template strand, not identical to it. Transcription produces a strand where each base pairs with its complement on the template.

Question 3: INTERMEDIATE

A researcher discovers a mutation in a eukaryotic gene that changes the conserved GU dinucleotide at the 5′ splice site of intron 3 to an AU dinucleotide. Which of the following is the most likely consequence of this mutation?

A. RNA Polymerase II will stall at the mutated site and fail to complete transcription.
B. The 5′ cap will not be added to the pre-mRNA because splicing is required before capping.
C. The spliceosome will fail to recognize the 5′ splice site of intron 3, likely leading to intron retention or exon skipping and production of an aberrant mRNA.
D. The poly-A tail will be added at the wrong position because splicing and polyadenylation use the same signal sequence.

Show answer (C)

C is correct. The conserved GU dinucleotide at the 5′ splice site is recognized by the U1 snRNP during spliceosome assembly. Mutating this sequence to AU would prevent proper U1 binding, resulting in failure to splice intron 3. This could cause intron retention (the intron remains in the mRNA, likely introducing premature stop codons) or exon skipping (the spliceosome uses a cryptic splice site, potentially excluding an exon). A is incorrect because RNA Pol II transcribes through introns without recognizing splice sites — splicing is a separate, post-transcriptional process. B is incorrect because 5′ capping occurs very early in transcription (after ~20–30 nucleotides), long before intron 3 is even transcribed. D is incorrect because polyadenylation depends on the AAUAAA signal, which is distinct from splice site sequences.

Question 4: APPLIED

4 pts

A research team hypothesizes that a newly identified protein, Factor X, is required for proper 5′ capping of mRNA in eukaryotic cells. Design an experiment to test this hypothesis. In your response: (a) Describe the experimental setup, including appropriate controls. (b) Identify the independent and dependent variables. (c) Describe the expected results if the hypothesis is supported. (d) Explain how improper 5′ capping would affect downstream gene expression.

Show answer

Point-by-point rubric (4 points): (a) Experimental design (1 point): Use RNA interference (siRNA) or CRISPR-Cas9 to knock down or knock out Factor X expression in cultured eukaryotic cells (experimental group). Maintain a control group of identical cells treated with a non-targeting siRNA (or wild-type cells without the CRISPR edit). Both groups should be grown under identical conditions. After a defined time period, isolate total mRNA from both groups and assess 5′ cap status using an anti-cap antibody immunoprecipitation assay or a cap-specific enzyme (such as Tobacco Acid Pyrophosphatase) followed by gel electrophoresis. (b) Variables (1 point): The independent variable is the presence or absence (or level) of functional Factor X protein. The dependent variable is the proportion of mRNA molecules that bear a proper 5′ 7-methylguanosine cap. Controlled variables include cell type, growth conditions, temperature, and duration of the experiment. (c) Expected results (1 point): If Factor X is required for 5′ capping, the experimental group (Factor X knockdown) should show a significant decrease in capped mRNA compared to the control group. Uncapped mRNA should be detected in the experimental group at higher levels, and total mRNA levels may decrease because uncapped transcripts are subject to rapid degradation. (d) Downstream effects (1 point): Without proper 5′ capping, mRNA molecules would be rapidly degraded by 5′ exonucleases, leading to decreased mRNA stability and reduced mRNA levels. Additionally, translation initiation would be impaired because the eukaryotic initiation factor eIF4E recognizes the 5′ cap to recruit the ribosome. Nuclear export might also be compromised because the cap-binding complex (CBC) facilitates transport through nuclear pores. The net result would be a dramatic reduction in protein synthesis from affected genes.

Question 5: CRITICAL THINKING

4 pts

Researchers studying the human tropomyosin gene find that this single gene produces different mRNA isoforms in skeletal muscle cells versus fibroblasts due to alternative splicing. In skeletal muscle, exons 1, 2, 3, 5, 7, 8, and 9 are included, while in fibroblasts, exons 1, 2, 4, 6, 8, and 9 are included. The pre-mRNA contains 9 exons and 8 introns. (a) Explain the molecular mechanism that allows a single gene to produce tissue-specific mRNA variants. (b) Predict how the proteins produced from these two mRNA isoforms would differ structurally and functionally. (c) A mutation eliminates the branch-point sequence in intron 4 (between exons 4 and 5). Predict the effect of this mutation on mRNA production in each tissue type. (d) Explain why alternative splicing is considered a mechanism that increases proteomic diversity beyond what would be predicted by gene number alone.

Show answer

Point-by-point rubric (4 points): (a) Molecular mechanism (1 point): Alternative splicing is regulated by tissue-specific splicing regulatory proteins — splicing activators (SR proteins) and splicing repressors (hnRNPs) — that bind to exonic or intronic splicing enhancers (ESE/ISE) and silencers (ESS/ISS) within the pre-mRNA. In skeletal muscle cells, a specific set of splicing regulators promotes inclusion of exons 3, 5, and 7 while excluding exons 4 and 6. In fibroblasts, a different complement of regulatory proteins promotes inclusion of exons 4 and 6 while excluding exons 3, 5, and 7. The spliceosome responds to these regulatory inputs to generate tissue-specific mRNA isoforms from the same primary transcript. (b) Structural and functional differences (1 point): Because different exons encode different amino acid sequences, the two protein isoforms would differ in portions of their primary structure (amino acid sequence), which could alter protein folding, domain composition, and interaction surfaces. The skeletal muscle isoform, containing exons 3, 5, and 7, likely has domains optimized for binding actin in sarcomeric thin filaments and regulating muscle contraction. The fibroblast isoform, containing exons 4 and 6, likely has domains suited for cytoskeletal organization in non-muscle cells. Both share regions encoded by common exons (1, 2, 8, 9), so they retain some functional similarity. (c) Effect of branch-point mutation (1 point): The branch-point sequence is essential for the first transesterification reaction of splicing. If the branch point in intron 4 is eliminated, intron 4 cannot be removed. In fibroblasts, where exon 4 is normally included, this mutation would cause intron 4 to be retained in the mature mRNA, likely introducing premature stop codons and producing a nonfunctional truncated protein (or triggering nonsense-mediated mRNA decay). In skeletal muscle, exon 4 (and its flanking intron 4) are normally excluded entirely during alternative splicing, so the mutation may have little or no effect if the spliceosome does not attempt to use the intron 4 branch point in this tissue. (d) Proteomic diversity (1 point): Alternative splicing allows a single gene to encode multiple distinct proteins by varying which exons are included in the final mRNA. The human genome contains approximately 20,000 protein-coding genes, yet the proteome contains an estimated 100,000+ distinct proteins. This discrepancy is largely explained by alternative splicing, which exponentially increases the coding potential of the genome without requiring additional genes. Each alternatively spliced isoform can have different functions, localizations, or regulatory properties, providing a powerful mechanism for generating biological complexity and enabling tissue-specific protein functions from a limited gene set.

SUMMARY

Lesson Summary

Summary

Transcription is the process by which RNA polymerase reads the template strand of DNA (3′→5′) and synthesizes a complementary RNA molecule (5′→3′). The process proceeds through three stages: initiation at a promoter (involving general transcription factors and the pre-initiation complex in eukaryotes), elongation (NTP addition via phosphodiester bond formation), and termination (rho-dependent/independent in prokaryotes; cleavage-polyadenylation in eukaryotes).

In eukaryotes, the primary transcript (pre-mRNA) undergoes three essential processing modifications: addition of a 5′ 7-methylguanosine cap for stability and translation initiation, addition of a 3′ poly-A tail (~100–250 adenines) for stability and export, and removal of introns by the spliceosome (composed of snRNPs), which joins exons into a continuous coding sequence. Alternative splicing allows a single gene to produce multiple mRNA isoforms, vastly expanding the proteomic diversity of eukaryotic organisms. These processing steps are absent in prokaryotes, where transcription and translation are coupled in the cytoplasm.